SEC
SlamSEC
BridgeBio Oncology Therapeutics, Inc. (Filer) CIK: 0001869105 (see all company filings)
10-K
PeriodDec 31, 2025
FiledMar 5, 2026
0001193125-26-094112
Documents
Contents
View on EDGAR ↗